FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2598256998> ?p ?o ?g. }

• W2598256998 abstract "Objective: We sought to compare the seroepidemiology of neuromyelitis optica and its spectrum disorders (NMOSD) across two ethnically divergent populations.Background: NMO/NMOSD are inflammatory demyelinating diseases (IDD) with a specific biomarker, aquaporin-4-IgG. Prior NMO/NMOSD epidemiological studies are limited by lack of aquaporin-4-IgG seroprevalence assessment, absence of population-based USA studies and under-representation of blacks.Methods: We performed a population-based comparative study of the incidence (2003-2011) and prevalence (on December 31, 2011) of NMO/NMOSD and aquaporin-4-IgG seroincidence and seroprevalence (sera collected in 80-84[percnt] of IDD) among patients with IDD diagnosis in Olmsted County, USA (82[percnt] white [Caucasian]) and Martinique (90[percnt] black [Afro-Caribbean]). Aquaporin-4-IgG was measured by M1-isoform-fluorescent-activated-cell-sorting assays.Results: The incidence (7.6 vs 0.8/1,000,000 person-years [p<0.01]) and prevalence (9.9 vs 4.1/100,000[p=0.04]) in Martinique exceeded that in Olmsted County. The AQP4-IgG seroincidence (6.8 vs 0.8/1,000,000 person-years [p=0.01]) and seroprevalence (7.9 vs 3.4/100,000[p=0.09]) was also higher in Martinique than Olmsted County. The ethnicity-specific prevalence was similar in Martinique and Olmsted County: 10.8 and 12.6/100,000 in blacks, and 5.1 and 4.1/100,000 in whites, respectively. NMO/NMOSD represented a higher proportion of IDD in Martinique than Olmsted County (16[percnt] vs 1.4[percnt]; p<0.01). The onset age (median, 35-37 years) and female:male distribution (8-9:1) were similar across both populations; 60[percnt] of prevalent cases were either blind in one eye, dependent on a gait aid or both.Conclusions: This study reports the highest prevalence of NMO/NMOSD in any population (9.9/100,000 in Martinique), estimates it affects 16,000-17,000 in the USA (higher than previous predictions) and demonstrates it disproportionately affects blacks. Disclosure: Dr. Flanagan has nothing to disclose. Dr. P. Cabre has received personal compensation for activities with Biogen Idec, EMD Serono and Novartis as consultant. Dr. Weinshenker has received personal compensation for activities with Novartis, Biogen Idec, Mitsubishi Pharmaceuticals, MedImmune Pharmaceuticals, Chugai, and Chord as a consultant. Dr. Weinshenker has received royalty payments from RSR Ltd. and Oxford Dr. St. Sauver has nothing to disclose. Dr. Majed has nothing to disclose. Dr. Lennon has received research support from the National Institutes of Health. Dr. Lucchinetti stands to receive royalty payments for commercial assays. Dr. McKeon has received research support from Medimmune. Dr. Wingerchuk has received personal compensation for serving on a clinical trial adjudication committee for Medimmune. Dr. Wingerchuk has received personal compensation in an editorial capacity for The Neurologist. Dr. Wingerchuk has received research su Dr. Mandrekar has nothing to disclose. Dr. Jacobson has nothing to disclose. Dr. Sagen has nothing to disclose. Dr. Schmeling has nothing to disclose. Dr. Fryer has nothing to disclose. Dr. Matiello has nothing to disclose. Dr. Kale has nothing to disclose. Dr. Borders Robinson has nothing to disclose. Dr. Pittock has received (royalty or license fee or contractual rights) payments from Peripherin-Specific Autoantibodies as a Marker for Neurological and Endocrinological Disease." @default.
• W2598256998 created "2017-04-07" @default.
• W2598256998 creator A5008002660 @default.
• W2598256998 creator A5012566800 @default.
• W2598256998 creator A5018724144 @default.
• W2598256998 creator A5026027610 @default.
• W2598256998 creator A5028997455 @default.
• W2598256998 creator A5029140980 @default.
• W2598256998 creator A5032891503 @default.
• W2598256998 creator A5035890515 @default.
• W2598256998 creator A5043673303 @default.
• W2598256998 creator A5049747855 @default.
• W2598256998 creator A5055122406 @default.
• W2598256998 creator A5058280348 @default.
• W2598256998 creator A5064378504 @default.
• W2598256998 creator A5069405668 @default.
• W2598256998 creator A5078400687 @default.
• W2598256998 creator A5088136783 @default.
• W2598256998 creator A5088810402 @default.
• W2598256998 creator A5088963233 @default.
• W2598256998 date "2016-04-05" @default.
• W2598256998 modified "2023-09-27" @default.
• W2598256998 title "Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum: A Comparison of Two Ethnically Divergent Populations (P3.003)" @default.
• W2598256998 hasPublicationYear "2016" @default.
• W2598256998 type Work @default.
• W2598256998 sameAs 2598256998 @default.
• W2598256998 citedByCount "0" @default.
• W2598256998 crossrefType "journal-article" @default.
• W2598256998 hasAuthorship W2598256998A5008002660 @default.
• W2598256998 hasAuthorship W2598256998A5012566800 @default.
• W2598256998 hasAuthorship W2598256998A5018724144 @default.
• W2598256998 hasAuthorship W2598256998A5026027610 @default.
• W2598256998 hasAuthorship W2598256998A5028997455 @default.
• W2598256998 hasAuthorship W2598256998A5029140980 @default.
• W2598256998 hasAuthorship W2598256998A5032891503 @default.
• W2598256998 hasAuthorship W2598256998A5035890515 @default.
• W2598256998 hasAuthorship W2598256998A5043673303 @default.
• W2598256998 hasAuthorship W2598256998A5049747855 @default.
• W2598256998 hasAuthorship W2598256998A5055122406 @default.
• W2598256998 hasAuthorship W2598256998A5058280348 @default.
• W2598256998 hasAuthorship W2598256998A5064378504 @default.
• W2598256998 hasAuthorship W2598256998A5069405668 @default.
• W2598256998 hasAuthorship W2598256998A5078400687 @default.
• W2598256998 hasAuthorship W2598256998A5088136783 @default.
• W2598256998 hasAuthorship W2598256998A5088810402 @default.
• W2598256998 hasAuthorship W2598256998A5088963233 @default.
• W2598256998 hasConcept C107130276 @default.
• W2598256998 hasConcept C120665830 @default.
• W2598256998 hasConcept C121332964 @default.
• W2598256998 hasConcept C126322002 @default.
• W2598256998 hasConcept C144024400 @default.
• W2598256998 hasConcept C149923435 @default.
• W2598256998 hasConcept C159654299 @default.
• W2598256998 hasConcept C187212893 @default.
• W2598256998 hasConcept C203014093 @default.
• W2598256998 hasConcept C2549261 @default.
• W2598256998 hasConcept C2778494684 @default.
• W2598256998 hasConcept C2778525166 @default.
• W2598256998 hasConcept C2780640218 @default.
• W2598256998 hasConcept C2781137167 @default.
• W2598256998 hasConcept C2908647359 @default.
• W2598256998 hasConcept C2909528719 @default.
• W2598256998 hasConcept C3018709324 @default.
• W2598256998 hasConcept C3018883866 @default.
• W2598256998 hasConcept C45189115 @default.
• W2598256998 hasConcept C61511704 @default.
• W2598256998 hasConcept C71924100 @default.
• W2598256998 hasConcept C72563966 @default.
• W2598256998 hasConcept C95457728 @default.
• W2598256998 hasConcept C99454951 @default.
• W2598256998 hasConceptScore W2598256998C107130276 @default.
• W2598256998 hasConceptScore W2598256998C120665830 @default.
• W2598256998 hasConceptScore W2598256998C121332964 @default.
• W2598256998 hasConceptScore W2598256998C126322002 @default.
• W2598256998 hasConceptScore W2598256998C144024400 @default.
• W2598256998 hasConceptScore W2598256998C149923435 @default.
• W2598256998 hasConceptScore W2598256998C159654299 @default.
• W2598256998 hasConceptScore W2598256998C187212893 @default.
• W2598256998 hasConceptScore W2598256998C203014093 @default.
• W2598256998 hasConceptScore W2598256998C2549261 @default.
• W2598256998 hasConceptScore W2598256998C2778494684 @default.
• W2598256998 hasConceptScore W2598256998C2778525166 @default.
• W2598256998 hasConceptScore W2598256998C2780640218 @default.
• W2598256998 hasConceptScore W2598256998C2781137167 @default.
• W2598256998 hasConceptScore W2598256998C2908647359 @default.
• W2598256998 hasConceptScore W2598256998C2909528719 @default.
• W2598256998 hasConceptScore W2598256998C3018709324 @default.
• W2598256998 hasConceptScore W2598256998C3018883866 @default.
• W2598256998 hasConceptScore W2598256998C45189115 @default.
• W2598256998 hasConceptScore W2598256998C61511704 @default.
• W2598256998 hasConceptScore W2598256998C71924100 @default.
• W2598256998 hasConceptScore W2598256998C72563966 @default.
• W2598256998 hasConceptScore W2598256998C95457728 @default.
• W2598256998 hasConceptScore W2598256998C99454951 @default.
• W2598256998 hasOpenAccess W2598256998 @default.
• W2598256998 hasRelatedWork W2040208407 @default.
• W2598256998 hasRelatedWork W2072134814 @default.
• W2598256998 hasRelatedWork W2333066855 @default.
• W2598256998 hasRelatedWork W2527246350 @default.
• W2598256998 hasRelatedWork W2581305480 @default.

• next